Middle East Africa Brain Health Supplements Market Report: Market Size & Forecast 2026

The Middle East and Africa Brain Health Supplements Market represents a specialized segment within the broader MEA dietary supplements industry, which is valued between $3.2 billion and $4.4 billion in 2025 and growing at approximately 9.8% to 10.1% annually depending on the geographic scope. The brain health sub-segment was valued at approximately $363 million in 2022 and is projected to reach roughly $658 million by 2028, translating to a $541 million valuation in 2026 at the midpoint of this growth curve. Products in this category typically include omega-3 and omega-6 fatty acids, herbal and botanical extracts, vitamins (particularly B-complex and D), minerals, amino acids, and antioxidants specifically positioned for cognitive support, memory enhancement, focus improvement, and neuroprotection.

• •Brain health supplements segment: ~$541 million in 2026, growing to ~$658 million by 2028 at 10.4% CAGR
• •Broader MEA dietary supplements market: $3.2B-$4.4B in 2025, growing at 9.75%-10.1% CAGR
• •Product categories span omega fatty acids, botanicals, vitamins, minerals, amino acids, and antioxidants targeting cognitive function

Rising health consciousness among aging populations in Gulf Cooperation Council countries is a primary catalyst, as growing awareness of neurodegenerative conditions and age-related cognitive decline drives demand for preventive supplementation. Expanding middle-class populations with higher disposable income across the region are allocating more household spending toward wellness products, including nootropic and cognitive-support supplements. Increased recognition of mental health as a critical component of overall wellbeing, accelerated by broader societal conversations around stress, anxiety, and cognitive performance, is broadening the consumer base beyond elderly demographics into younger, working-age populations seeking mental clarity and stress resilience.

• •Aging populations in GCC states driving preventive healthcare spending on cognitive wellness
• •Rising disposable income and expanding middle class increasing supplement purchasing power
• •Growing mental health awareness broadening the consumer base across age demographics

The market is segmented by product type (herbal supplements, vitamins and minerals, omega fatty acids, amino acids, and antioxidants), dosage form (capsules, tablets, powders, soft gels, and liquids), application (memory enhancement, focus and attention, mood and stress, sleep support, and neuroprotection), and distribution channel (pharmacies, health stores, hospitals and clinics, online retail, and supermarkets). Geographically, the Gulf Cooperation Council nations, particularly Saudi Arabia, the United Arab Emirates, and Qatar, command the largest market share due to higher healthcare expenditure, well-developed retail infrastructure, and greater consumer purchasing power. South Africa represents a significant secondary market with a more mature regulatory environment, while the broader Sub-Saharan Africa region presents emerging opportunities driven by urbanization and improving economic conditions.

• •GCC states (Saudi Arabia, UAE, Qatar) dominate market share with highest per-capita supplement spending
• •South Africa is a key secondary market with relatively developed supplement regulatory frameworks
• •Urbanization and rising health consciousness across Sub-Saharan Africa creating emerging growth opportunities

Who are the notable companies in the industry?

The Middle East Africa brain health supplements market presents a fragmented competitive landscape shaped by three distinct producer tiers. At the multinational level, Danone leverages its broad nutritional portfolio and vertically integrated supply chain to anchor its positioning across mass-market cognitive wellness segments. HVMN Inc. occupies a differentiated specialty niche, concentrating on nootropic formulation innovation and science-backed positioning to reach performance-oriented consumers. Motiva Supplements operates as a more agile regional player, tailoring formulations to local regulatory and cultural preferences while navigating import dependencies for key raw materials. Across the sector, operators vary widely in production models, some pursuing full integration from sourcing through formulation and distribution, while others rely on contract manufacturing partnerships or focus exclusively on product development. Key feedstock corridors link the region to suppliers of omega-3 oils, botanical extracts, synthetic vitamins, and fermented amino acids, with manufacturing activity clustering in GCC, South African, and North African hubs.

• •Market remains fragmented across multinational diversified players, regional producers, and specialty supplement manufacturers
• •Production ranges from fully integrated vertically structured operations to contract manufacturing and formulation-specialist models
• •Manufacturing capacity concentrated in GCC states and South Africa, with heavy reliance on imported raw materials and finished products

What are the recent trends and outlook?

The market is positioned for sustained expansion through 2030 as demographic tailwinds, rising health consciousness, and improving regulatory frameworks converge to support industry maturation. Natural and plant-based formulations are gaining preference among consumers, driving innovation in herbal and botanical brain health products with traditional medicinal roots. Personalization and customization of supplement regimens, enabled by digital health platforms and increased consumer education, represent an emerging frontier, as does the integration of brain health supplements into broader digital wellness ecosystems. Regulatory harmonization efforts across MEA markets and increased investment in local manufacturing capacity are expected to strengthen the competitive environment and potentially moderate import dependency over the medium term.

• •Natural and plant-based formulations gaining consumer preference, driving botanical supplement innovation
• •Digital health platforms enabling personalized supplement regimens and direct-to-consumer distribution models
• •Increasing regulatory harmonization and local manufacturing investments expected to reshape supply chains by 2030